Treatment of Chronic Stroke With AMES + EMG Biofeedback "AMES"

Active, not recruiting

Phase 1/2 Results N/A

Summary of Purpose

The purpose of this study is to determine if individuals who had a stroke more than one year before entering the study and who remain unable to open their affected hand are better able to sense and move their affected arm after 10-15 weeks of treatment with a new robotic therapy device (the AMES device) and EMG biofeedback.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 19 December 2014.

1 Apr 2010 3 May 2010 1 Dec 2013 1 Dec 2014 1 Dec 2014 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Single Blind (Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment


Not available